Trading the Biotech Bottom in 2018 in an Ambivalent Market…Updates ASH TSRO XBI
Update-2 December 3 ...Our Top Pick TSRO is up 58% on GSK Buyout We recommended Tesaro (TSRO) at $34 and it paid off today with a ~$5.1B buyout by GlaxoSmith Kline! Year End Rally Intact with XBI up over 3% to $84 handle, ====== Update-1 December 1... NASDAQ Rallies 0.79% on Nov 30 Our recent...
Trade the Seasonal Rally in Biotech Off the 2018 Bottom…Updates AMGN TSRO XBI
Update for the Week: Trying to Find the Bottom-Choppy Action But Tradeable XBI holds above $74.62 bottom up 1.3% for the week but can't hold today's gains. AMGN flat for the week at $193 but can't hold gains at mid-week. Big winner TSRO up 64.9% for week now at $43. Tape looking better with...
2018 Biopharmaceutical Performance-Large Caps: Big winners were Merck and Vertex…Update- Rally Underway
11/16...TSRO Alert at $35, Up 32%, Company is for Sale 11/15p After Close...Traders: Rally is intact but needs another green day to confirm. Big mid-cap 4% movers today: AGIO ARNA (up 21.6%) ARRY CRSP LOXO NBIX ICPT SRPT XNCR We added small positions over the past week in ABBV AMRN KPTI QQQ...
Biotech Bear Market: But It Is Time to Start Trading…11/9 Updates on Rally
Update at Close 11/9/18 Remain Cautious as Rally Fails The NASDAQ down 1.6% and Russell 2000 down 1.8%, sold off killing hopes of a continued Post-Election rally. The biotech sector is for experienced traders only. The healthcare still looks good overall with the XLV down only 0.29% at $92.95....
Biotech Bull Market Under Pressure: Now Flat to Down in 2018…Rally 10/16!…Updates 10/29 Bear Market
Update 10/29 It's a bear market in biotech so wait for the bottom. Have plenty of cash on hand. IBB at $102.77 down over 5% YTD. Clues: IJR and XBI need to bottom. ======= Update 10/27 Still on vacation, nothing to do . Impossible to trade or invest right now. Sentiment is crushed and numbers...